All Curated Mutation Sites in HIV

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HIV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Keyword: HIV Infections-32106437

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	32106437	A128T	IN	gag-pol	HIV Infections	D G S C L	View
2	32106437	A21T	IN	gag-pol	HIV Infections	D G S C L	View
3	32106437	A9071G	LTR		HIV Infections	D G R S C L	View
4	32106437	A9075T	LTR		HIV Infections	G R S C L	View
5	32106437	A9076C	LTR		HIV Infections	D G R S C L	View
6	32106437	C9063A	LTR		HIV Infections	D G S C L	View
7	32106437	C9063T	Nef	Nef	HIV Infections	D G R S C L	View
8	32106437	D167E	IN	gag-pol	HIV Infections	D G S C L	View
9	32106437	D256E	IN	gag-pol	HIV Infections	D G S C L	View
10	32106437	E11D	IN	gag-pol	HIV Infections	D G S C L	View
11	32106437	E138D	IN	gag-pol	HIV Infections	D G S C L	View
12	32106437	E157Q	IN	gag-pol	HIV Infections	D G S C L	View
13	32106437	G134D	IN	gag-pol	HIV Infections	D G S C L	View
14	32106437	G134N	IN	gag-pol	HIV Infections	D G S C L	View
15	32106437	G9078T	LTR		HIV Infections	G R S C L	View
16	32106437	G9081A	LTR		HIV Infections	G R S C L	View
17	32106437	I135V	IN	gag-pol	HIV Infections	D G S C L	View
18	32106437	I208L	IN	gag-pol	HIV Infections	D G S C L	View
19	32106437	I72V	IN	gag-pol	HIV Infections	D G S C L	View
20	32106437	K136Q	IN	gag-pol	HIV Infections	D G S C L	View
21	32106437	K136T	IN	gag-pol	HIV Infections	D G S C L	View
22	32106437	K14R	IN	gag-pol	HIV Infections	D G S C L	View
23	32106437	L101I	IN	gag-pol	HIV Infections	D G S C L	View
24	32106437	L234I	IN	gag-pol	HIV Infections	G S C L	View
25	32106437	L63I	IN	gag-pol	HIV Infections	G S C L	View
26	32106437	L74I	IN	gag-pol	HIV Infections	D G S C L	View
27	32106437	L74M	IN	gag-pol	HIV Infections	D G S C L	View
28	32106437	M50I	IN	gag-pol	HIV Infections	D G S C L	View
29	32106437	N155K	IN	gag-pol	HIV Infections	D G S C L	View
30	32106437	R20K	IN	gag-pol	HIV Infections	G S C L	View
31	32106437	R269K	IN	gag-pol	HIV Infections	D G S C L	View
32	32106437	S119R	IN	gag-pol	HIV Infections	D G S C L	View
33	32106437	S230N	IN	gag-pol	HIV Infections	D G S C L	View
34	32106437	S24N	IN	gag-pol	HIV Infections	G S C L	View
35	32106437	S283G	IN	gag-pol	HIV Infections	G S C L	View
36	32106437	T112I	IN	gag-pol	HIV Infections	G S C L	View
37	32106437	T112V	IN	gag-pol	HIV Infections	D G S C L	View
38	32106437	T124A	IN	gag-pol	HIV Infections	D G S C L	View
39	32106437	T125A	IN	gag-pol	HIV Infections	D G S C L	View
40	32106437	T206S	IN	gag-pol	HIV Infections	D G S C L	View
41	32106437	T214A	IN	gag-pol	HIV Infections	D G S C L	View
42	32106437	T218I	IN	gag-pol	HIV Infections	D G S C L	View
43	32106437	T66A	IN	gag-pol	HIV Infections	D G S C L	View
44	32106437	T9086G	LTR		HIV Infections	D G R S C L	View
45	32106437	T97A	IN	gag-pol	HIV Infections	D G S C L	View
46	32106437	V201I	IN	gag-pol	HIV Infections	D G S C L	View
47	32106437	V31I	IN	gag-pol	HIV Infections	D G S C L	View

Contents
Description

The table shows all curated mutation sites of HIV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.